Antidepressants and anxiolytics: Novel tablet formulations
Antidepresivi i anksiolitici - novine u formulaciji tableta
Апстракт
Development of new dosage forms with uncompromised efficacy, safety and stability and improved tolerability and dosage regimen that would result in better patient compliance is an imperative in modern pharmacotherapy. Patients" adherence to dosage regimen is of great importance, especially when prolonged treatment is an issue. Therefore, novelties in formulation development for antidepressants and anxiolytics are directed towards the modified/sustained or extended release drug products and orally disintegrating tablets. There is a number and variety of new technologies employed with this respect. In the present paper, an overview of the most important technologies applied in commercially available drug products within the group of antidepressants and anxiolytics is given.
Извор:
Arhiv za farmaciju, 2007, 57, 1-2, 94-105Издавач:
- Savez farmaceutskih udruženja Srbije, Beograd
Институција/група
PharmacyTY - JOUR AU - Parojčić, Jelena AU - Ibrić, Svetlana AU - Đurić, Zorica PY - 2007 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/961 AB - Development of new dosage forms with uncompromised efficacy, safety and stability and improved tolerability and dosage regimen that would result in better patient compliance is an imperative in modern pharmacotherapy. Patients" adherence to dosage regimen is of great importance, especially when prolonged treatment is an issue. Therefore, novelties in formulation development for antidepressants and anxiolytics are directed towards the modified/sustained or extended release drug products and orally disintegrating tablets. There is a number and variety of new technologies employed with this respect. In the present paper, an overview of the most important technologies applied in commercially available drug products within the group of antidepressants and anxiolytics is given. PB - Savez farmaceutskih udruženja Srbije, Beograd T2 - Arhiv za farmaciju T1 - Antidepressants and anxiolytics: Novel tablet formulations T1 - Antidepresivi i anksiolitici - novine u formulaciji tableta VL - 57 IS - 1-2 SP - 94 EP - 105 UR - https://hdl.handle.net/21.15107/rcub_farfar_961 ER -
@article{ author = "Parojčić, Jelena and Ibrić, Svetlana and Đurić, Zorica", year = "2007", abstract = "Development of new dosage forms with uncompromised efficacy, safety and stability and improved tolerability and dosage regimen that would result in better patient compliance is an imperative in modern pharmacotherapy. Patients" adherence to dosage regimen is of great importance, especially when prolonged treatment is an issue. Therefore, novelties in formulation development for antidepressants and anxiolytics are directed towards the modified/sustained or extended release drug products and orally disintegrating tablets. There is a number and variety of new technologies employed with this respect. In the present paper, an overview of the most important technologies applied in commercially available drug products within the group of antidepressants and anxiolytics is given.", publisher = "Savez farmaceutskih udruženja Srbije, Beograd", journal = "Arhiv za farmaciju", title = "Antidepressants and anxiolytics: Novel tablet formulations, Antidepresivi i anksiolitici - novine u formulaciji tableta", volume = "57", number = "1-2", pages = "94-105", url = "https://hdl.handle.net/21.15107/rcub_farfar_961" }
Parojčić, J., Ibrić, S.,& Đurić, Z.. (2007). Antidepressants and anxiolytics: Novel tablet formulations. in Arhiv za farmaciju Savez farmaceutskih udruženja Srbije, Beograd., 57(1-2), 94-105. https://hdl.handle.net/21.15107/rcub_farfar_961
Parojčić J, Ibrić S, Đurić Z. Antidepressants and anxiolytics: Novel tablet formulations. in Arhiv za farmaciju. 2007;57(1-2):94-105. https://hdl.handle.net/21.15107/rcub_farfar_961 .
Parojčić, Jelena, Ibrić, Svetlana, Đurić, Zorica, "Antidepressants and anxiolytics: Novel tablet formulations" in Arhiv za farmaciju, 57, no. 1-2 (2007):94-105, https://hdl.handle.net/21.15107/rcub_farfar_961 .